Provided by Tiger Trade Technology Pte. Ltd.

Arvinas Holding Company LLC

7.64
+0.13001.73%
Post-market: 7.640.1300+1.73%16:00 EDT
Volume:557.64K
Turnover:4.26M
Market Cap:499.55M
PE:57.15
High:7.74
Open:7.46
Low:7.46
Close:7.51
52wk High:14.51
52wk Low:6.97
Shares:65.39M
Float Shares:56.67M
Volume Ratio:0.81
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1337
EPS(LYR):-1.1400
ROE:1.59%
ROA:-1.01%
PB:0.89
PE(LYR):-6.70

Loading ...

U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic

Reuters
·
May 13

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and Sensus Healthcare (SRTS)

TIPRANKS
·
May 13

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

TIPRANKS
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Tyler Technologies, Autodesk, Illumina

Reuters
·
May 13

Arvinas Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

BUZZ-U.S. STOCKS ON THE MOVE-Under Armour, C3 AI, Rigel Pharma

Reuters
·
May 12

Arvinas Grants Rigel Global Rights to VEPPANU Therapy

TIPRANKS
·
May 12

Arvinas publishes corporate presentation on PROTAC protein degraders in cancer, neurodegenerative diseases

Reuters
·
May 12

Arvinas, Pfizer Tap Rigel Pharmaceuticals to Bring Veppanu to Market

Dow Jones
·
May 12

Arvinas Q1 sales miss estimates on lower collaboration revenue from Pfizer

Reuters
·
May 12

Arvinas Q1 EPS $(0.90) Misses $(0.87) Estimate, Sales $15.600M Miss $18.097M Estimate

Benzinga Earnings
·
May 12

BRIEF-Arvinas Q1 Operating Expenses USD 79.4 Million

Reuters
·
May 12

Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 12

Arvinas Q1 Basic EPS USD -0.9

THOMSON REUTERS
·
May 12

Arvinas Q1 Net Income USD -57.6 Million VS. Ibes Estimate USD -61.5 Million

THOMSON REUTERS
·
May 12

Rigel licenses breast cancer drug VEPPANU from Arvinas, Pfizer for USD 70 million

Reuters
·
May 12

Arvinas Inc - and Pfizer to Receive $85 Mln in Upfront and Transition Payments

THOMSON REUTERS
·
May 12

Arvinas Inc - and Pfizer Eligible for up to $320 Mln in Milestone Payments and Tiered Royalties

THOMSON REUTERS
·
May 12

Arvinas and Pfizer Enter Into a Transaction With Rigel Pharmaceuticals for the Exclusive Global Rights of Veppanu (Vepdegestrant)

THOMSON REUTERS
·
May 12

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

GlobeNewswire
·
May 12